121-135 of 238
Strategies for Managing Depression in Long-Term Care
Advances in Long Term Care MedicineStrategies for Managing Depression in Long-Term Care
Jay Luxenberg, MD
Eric Tangalos, MD
New Frontiers and Challenges for Alzheimer's Drugs
Focus on Neurology and PsychiatryNew Frontiers and Challenges for Alzheimer's Drugs
William Thies, PhD
Bruce Japsen
Initiating Insulin Therapy for Type 2 Diabetes
Diabetes DiscourseInitiating Insulin Therapy for Type 2 Diabetes
Anne Louise Peters, MD
Steven Edelman, MD
Potentially Huge Savings When Patients Adhere to their Prescriptions
Clinician's RoundtablePotentially Huge Savings When Patients Adhere to their Prescriptions
Steve Miller, MD
Bruce Japsen
Repurposing Drugs: Challenges and Triumphs from an Emerging Field
Proto: Dispatches from the Frontiers of MedicineRepurposing Drugs: Challenges and Triumphs from an Emerging Field
Frances Toneguzzo, PhD
Bruce Bloom, DDS, JD
David Borsook, MD, PhD
Charles Turck, PharmD, BCPS, BCCCP
- advertisement
The Benefits of TZDs for Early Type 2 Diabetes
Diabetes DiscourseThe Benefits of TZDs for Early Type 2 Diabetes
John (Jack) L. Leahy, MD
Steven Edelman, MD
Oral Agents for Diabetes: What to Choose and When
Diabetes DiscourseOral Agents for Diabetes: What to Choose and When
Andrew Ahmann, MD
Steven Edelman, MD
The Battle Continues Against Pharmacological Cheating in Sports
Focus on Sports MedicineThe Battle Continues Against Pharmacological Cheating in Sports
Gary Wadler, MD
Bruce Japsen
Darrel Regier, MD
Bruce Japsen
Multiple Choice: Customizing Insulin Therapy
Diabetes DiscourseMultiple Choice: Customizing Insulin Therapy
Matthew Riddle, MD
Steven Edelman, MD
As Prescribed: Meeting the Challenges of Medication Adherence
Heart MattersAs Prescribed: Meeting the Challenges of Medication Adherence
Janet Wright, MD
Michael Ho, MD, PhD
- advertisement
In-Office Drug Testing for Retinal Conditions
Revealing RetinaIn-Office Drug Testing for Retinal Conditions
Roy Levit, MD
Allen Verne, MD
Debra Simmons, MD
Steven Edelman, MD
The Potential of Immunotherapy in Type 1 Diabetes
Diabetes DiscourseThe Potential of Immunotherapy in Type 1 Diabetes
Matthias von Herrath, MD
Steven Edelman, MD
